{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:49:21Z","timestamp":1780620561046,"version":"3.54.1"},"reference-count":38,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T00:00:00Z","timestamp":1651795200000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Midwife Womens Health"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This article describes 2 innovative models of advanced practice provider\u2013led medication for opioid use disorder treatment programs offering comprehensive, interprofessional care for pregnant patients and provides implications for broader adaptation of practice. Increasing the number of midwives and nurse practitioners waivered to prescribe buprenorphine and able to connect pregnant patients with opioid use disorder to appropriate community\u2010based resources, treatment, and self\u2010help programs could address alarming substance use trends including overdose deaths and other sequelae associated with the opioid epidemic.<\/jats:p>","DOI":"10.1111\/jmwh.13372","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T13:36:07Z","timestamp":1651844167000},"page":"384-393","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Advanced Practice Provider\u2013Led Medication for Opioid Use Disorder Programs for Pregnant and Parenting Women"],"prefix":"10.1111","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5971-2326","authenticated-orcid":false,"given":"Dolly","family":"Pressley Byrd","sequence":"first","affiliation":[{"name":"Ob\/Gyn Specialists Mountain Area Health Education Center (MAHEC)  Asheville North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley","family":"Galvin","sequence":"additional","affiliation":[{"name":"Ob\/Gyn Specialists Mountain Area Health Education Center (MAHEC)  Asheville North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Ramage","sequence":"additional","affiliation":[{"name":"Ob\/Gyn Specialists Mountain Area Health Education Center (MAHEC)  Asheville North Carolina"},{"name":"Project CARA Mountain Area Health Education Center (MAHEC)  Asheville North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Johnson","sequence":"additional","affiliation":[{"name":"UNC Horizons, Department of Obstetrics &amp; Gynecology University of North Carolina  Chapel Hill North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,5,6]]},"reference":[{"key":"e_1_2_6_2_1","unstructured":"Understanding the epidemic. Centers for Disease Control and Prevention. March 17 2021. Accessed September 19 2021.https:\/\/www.cdc.gov\/opioids\/basics\/epidemic.html"},{"key":"e_1_2_6_3_1","unstructured":"Increase in fatal drug overdoses across the United States driven by synthetic opioids before and during the COVID\u201019 pandemic. News release. Centers for Disease Control and Prevention. December 17 2020. Accessed September 18 2021.https:\/\/emergency.cdc.gov\/han\/2020\/han00438.asp#:~text=The%20most%20recent%20provisional%20data May%202020%20(Figure%201)."},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6801a1"},{"key":"e_1_2_6_5_1","volume-title":"2019 National Survey on Drug Use and Health: Women","author":"Substance Abuse and Mental Health Services Administration"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2010.08.011"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1177\/1178221819852637"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596"},{"key":"e_1_2_6_9_1","unstructured":"Opioid use disorder. American Psychiatric Association. November 2018. Accessed November 4 2021.https:\/\/www.psychiatry.org\/patients\u2010families\/addiction\/opioid\u2010use\u2010disorder"},{"key":"e_1_2_6_10_1","unstructured":"Drug Addiction Treatment Act of 2000 HR 2634 106th Cong (2000).https:\/\/www.congress.gov\/bill\/106th\u2010congress\/house\u2010bill\/2634"},{"key":"e_1_2_6_11_1","unstructured":"Comprehensive Addiction and Recovery Act Pub L No. 114\u2010198 130 Stat 695 (2016).https:\/\/www.congress.gov\/114\/plaws\/publ198\/PLAW\u2010114publ198.pdf"},{"key":"e_1_2_6_12_1","unstructured":"Substance Use\u2010Disorder Prevention That Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act Pub L 115\u2010271 132 Stat 3894 (2018).https:\/\/www.congress.gov\/115\/plaws\/publ271\/PLAW\u2010115publ271.pdf"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002493"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000000472"},{"key":"e_1_2_6_15_1","volume-title":"Medicaid and Health Choice Clinical Coverage Policy No: 8\u2010A","year":"2019"},{"key":"e_1_2_6_16_1","volume-title":"Trauma\u2010Informed Care in Behavioral Health Services","author":"Substance Abuse and Mental Health Services Administration","year":"2014"},{"issue":"1","key":"e_1_2_6_17_1","first-page":"55","article-title":"Managing maternal substance use in the perinatal period: current concerns and treatment approaches in the United States and Australia","volume":"10","author":"Burns L","year":"2016","journal-title":"Subst Abus"},{"key":"e_1_2_6_18_1","volume-title":"Substance Use in Women Research Report","author":"National Institute on Drug Abuse","year":"2020"},{"key":"e_1_2_6_19_1","volume-title":"Substance Abuse Treatment: Addressing the Specific Needs of Women","author":"Substance Abuse and Mental Health Services Administration","year":"2009"},{"key":"e_1_2_6_20_1","volume-title":"Guidelines for Identification and Management of Substance Use and Substance Use Disorders in Pregnancy","author":"World Health Organization","year":"2014"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002235"},{"key":"e_1_2_6_22_1","volume-title":"Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants","author":"Substance Abuse and Mental Health Services Administration","year":"2018"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002633"},{"key":"e_1_2_6_24_1","volume-title":"Vermont Hub\u2010and\u2010Spokes Model of Care for Opioid Use Disorders: An Evaluation","author":"Rawson RA","year":"2017"},{"key":"e_1_2_6_25_1","unstructured":"Moms in Recovery. Dartmouth Hitchcock Medical Center and Clinics. Accessed November 24 2021.https:\/\/www.dartmouth\u2010hitchcock.org\/psychiatry\/moms\u2010recovery"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/jmwh.13320"},{"key":"e_1_2_6_27_1","unstructured":"Waiver training for advanced practice registered nurses (APRNs). Provider Clinical Services Support. Accessed September 28 2021.https:\/\/pcssnow.org\/medications\u2010for\u2010opioid\u2010use\u2010disorder\/waiver\u2010training\u2010for\u2010nurses\/"},{"key":"e_1_2_6_28_1","unstructured":"HHS Releases New Buprenorphine Practice Guidelines Expanding Access to Treatment for Opioid Use Disorder. Washington DC: US Department of Health and Human Services;2021. Accessed May 1 2022.https:\/\/www.hhs.gov\/about\/news\/2021\/04\/27\/hhs-releases-new-buprenorphine-practice-guidelines-expanding-access-to-treatment-for-opioid-use-disorder.html3gurl"},{"issue":"345","key":"e_1_2_6_29_1","first-page":"1","article-title":"Urban\u2010rural differences in drug overdose death rates, by sex, age, and type of drugs involved","author":"Hedegaard H","year":"2019","journal-title":"NCHS Data Brief"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1177\/1077558718793070"},{"key":"e_1_2_6_31_1","volume-title":"COVID\u201019 Pandemic Impact on Patients, Families and Individuals in Recovery from Substance Use Disorders","author":"Hulsey J"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.15582"},{"key":"e_1_2_6_33_1","volume-title":"A Practical Guide to Intervention in Health and Social Services with Pregnant and Postpartum Addicts and Alcoholics: Theoretical Framework, Brief Screening Tool, Key Interview Questions, and Strategies for Referral to Recovery Resources","author":"Ewing H","year":"1990"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1023\/B:MACI.0000037647.78420.e3"},{"key":"e_1_2_6_35_1","unstructured":"The 4P's Plus Screening Instrument.NTI Upstream. Accessed April 9 2022.https:\/\/www.ntiupstream.com\/4psabout#"},{"key":"e_1_2_6_36_1","volume-title":"The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): Manual for Use in Primary Care","author":"Humeniuk RE","year":"2010"},{"key":"e_1_2_6_37_1","unstructured":"CRAFFT. Updated 2021. Accessed April 9 2022.https:\/\/crafft.org\/"},{"key":"e_1_2_6_38_1","volume-title":"Screening for Drug Use in General Medical Settings: Resource Guide","author":"National Institute on Drug Abuse"},{"key":"e_1_2_6_39_1","volume-title":"Substance Use During Pregnancy","author":"Guttmacher Institute","year":"2022"}],"container-title":["Journal of Midwifery &amp; Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jmwh.13372","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jmwh.13372","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jmwh.13372","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T08:57:41Z","timestamp":1692608261000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jmwh.13372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["10.1111\/jmwh.13372"],"URL":"https:\/\/doi.org\/10.1111\/jmwh.13372","archive":["Portico"],"relation":{},"ISSN":["1526-9523","1542-2011"],"issn-type":[{"value":"1526-9523","type":"print"},{"value":"1542-2011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"2021-11-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}